$108.15
0.000.00%
Pre-Market: Mar 21, 4:00 PM EDT
Comments
Loading...
Ligand Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:LGND | Benzinga
Ligand Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$1.340
Quarterly Revenue Estimate
$36.01M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$167.13M
Analyze the earnings history of Ligand Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals | $3.84 | $1.34 | — | — | $30.98M | $36.01M | — | — | 05/06/2025 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.38 | $1.19 | $1.27 | 6.72% | $28.10M | $39.03M | $42.81M | 9.69% | 02/27/2025 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.02 | $1.35 | $1.84 | 36.30% | $32.87M | $40.65M | $51.81M | 27.46% | 11/07/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.42 | $0.98 | $1.40 | 42.86% | $26.37M | $31.90M | $41.53M | 30.19% | 08/06/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $2.28 | $0.78 | $3.84 | 392.31% | $43.98M | $27.92M | $30.98M | 10.95% | 05/07/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.36 | $0.66 | $1.38 | 109.09% | $50.38M | $25.72M | $28.10M | 9.26% | 02/27/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.60 | $0.61 | $1.02 | 67.21% | $59.22M | $27.19M | $32.87M | 20.88% | 11/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.03 | $0.64 | $1.42 | 121.88% | $57.42M | $25.73M | $26.37M | 2.47% | 08/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.76 | $0.89 | $2.28 | 156.18% | $45.69M | $34.04M | $43.98M | 29.20% | 05/04/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.80 | $1.19 | $1.36 | 14.29% | $72.47M | $46.64M | $50.38M | 8.02% | 02/22/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.58 | $0.43 | $1.31 | 204.65% | $64.83M | $38.28M | $66.09M | 72.64% | 11/07/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.63 | $0.43 | $1.03 | 139.53% | $84.67M | $37.73M | $57.42M | 52.18% | 08/08/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.41 | $0.66 | $0.76 | 15.15% | $55.15M | $34.21M | $45.69M | 33.57% | 05/04/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.62 | $1.37 | $1.80 | 31.39% | $69.99M | $65.32M | $72.47M | 10.95% | 02/17/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.04 | $1.04 | $1.58 | 51.92% | $41.85M | $55.65M | $64.83M | 16.50% | 11/09/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.00 | $1.34 | $1.63 | 21.64% | $41.42M | $70.41M | $84.67M | 20.26% | 07/29/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.89 | $1.12 | $1.41 | 25.89% | $33.16M | $62.85M | $55.15M | -12.25% | 05/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.71 | $0.99 | $1.62 | 63.64% | $27.00M | $54.09M | $69.99M | 29.40% | 02/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.49 | $0.98 | $1.04 | 6.12% | $24.81M | $44.36M | $41.85M | -5.66% | 10/30/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.68 | $0.76 | $1.00 | 31.58% | $24.99M | $29.96M | $41.42M | 38.25% | 08/03/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.16 | $0.66 | $0.89 | 34.85% | $43.48M | $26.53M | $33.16M | 24.99% | 05/06/2020 | Get Alert |
Ligand Pharmaceuticals (LGND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $1.27 | $1.19 | 6.72 % |
| Q3 | 2024-11-07 | $1.84 | $1.35 | 36.3 % |
| Q2 | 2024-08-06 | $1.40 | $0.98 | 42.9 % |
| Q1 | 2024-05-07 | $3.84 | $0.78 | 392.3 % |
Ligand Pharmaceuticals (LGND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $42.81M | $39.03M | 9.69 % |
| Q3 | 2024-11-07 | $51.81M | $40.65M | 27.5 % |
| Q2 | 2024-08-06 | $41.53M | $31.90M | 30.2 % |
| Q1 | 2024-05-07 | $30.98M | $27.92M | 10.9 % |
FAQ
When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?
Ligand Pharmaceuticals (LGND) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Ligand Pharmaceuticals (NASDAQ:LGND)?
The Actual EPS was $1.27, which beat the estimate of $1.19.
What were Ligand Pharmaceuticals’s (NASDAQ:LGND) revenues?
The Actual Revenue was $42.8M, which beat the estimate of $39M.
Browse earnings estimates, EPS, and revenue on all stocks.